Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$35,141
-0.66%
Shares
Shares Volume: 1,270 Shares
Average Share Price: $27.67
INSIDER
Heyman Richard A.
(Director)
reported on Oct 17 2024
traded on Oct 15 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 189,815 |
| PURCHASES/SALES 1Y | 0 / 19 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $32,263.39 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 93 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $891,316.18 |
| COMPANY PREVIOUS TRADES |